Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Ahlmark M et al. |
Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel clodronic acid dianhydrides as bioreversible prodrugs of clodronate.
|
2 |
Antopolsky M, Azhayev A. |
Stepwise solid-phase synthesis of peptide-oligonucleotide conjugates on new solid supports.
|
3 |
Antopolsky M et al. |
Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties.
|
4 |
Antopolsky M et al. |
General method to synthesize disulfide cross-linked peptide-oligonucleotide phosphorothioate conjugates.
|
5 |
Auriola S et al. |
Analysis of adenine nucleotide containing metabolite of clodronate using ion pair HPLC-ESI-MS.
|
6 |
Azhayev A. |
Universal solid supports for oligonucleotide synthesis.
|
7 |
Azhayev AV. |
A new universal solid support for oligonucleotide synthesis.
|
8 |
Benford HL et al. |
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs.
|
9 |
Callaway JC. |
Phytochemistry and neuropharmacology of ayahuasca.
|
10 |
Callaway JC et al. |
Pharmacokinetics of hoasca alkaloids in healthy humans.
|
11 |
Fredholt K et al. |
Alfa-chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins.
|
12 |
Guzaev A et al., inventor. |
Chemical phosphorylation of oligonucleotides and reactants used therefor.
|
13 |
Gynther J, Järvinen T. |
Kuopion yliopistossa kehitetään uusia lääkeaineita.
|
14 |
Haataja S et al. |
Determination of the cell adhesion specificity of Streptococcus suis with the complete set of monodeoxy analogues of globotriose.
|
15 |
Hakala K et al. |
Mass spectrometric (HPLC/ESI-MS/MS) quantification of pyrimido[1,2-a]purin-10(3H)-one, a guanine adduct formed by reaction of malondialdehyde with DNA.
|
16 |
Kovalainen JT et al. |
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-amino-3-(1H-imidazol-4(5)-yl) propyl ether derivatives.
|
17 |
Kovalainen JT et al. |
1H NMR study on putative intramolecular hydrogen bonding for histamine H3-receptor agonists.
|
18 |
Kovalainen JT et al. |
4-(3-(4-iodophenylmethoxy)propyl)-1H-imidazolium hydrogen maleate (iodoproxyfan hydrogen maleate).
|
19 |
Loftssona T, Järvinen T. |
Cyclodextrins in ophthalmic drug delivery.
|
20 |
Makkonen N et al. |
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
|
21 |
Mönkkönen J et al. |
Effects of bisphosphonates on the inflammatory processes of activated macrophages.
|
22 |
Niemi R et al. |
Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel acyloxyalkyl esters of clodronic acid.
|
23 |
Pate DW. |
Anandamide Structure-Activity Relationships and Mechanisms of Action on Intraocular Pressure in the Normotensive Rabbit Model.
|
24 |
Pate DW et al., inventor. |
Anandamide analog compositions and method of treating intraocular hypertension using same.
|
25 |
Rautio J et al. |
Synthesis and in vitro evaluation of aminoacyloxyalkyl esters of 2-(6-methoxy-2-naphthyl) propionic acid as novel naproxen prodrugs for dermal drug delivery.
|
26 |
Rogers MJ et al. |
Molecular mechanisms of action of bisphosphonates.
|
27 |
Savolainen J et al. |
Coadministration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
|
28 |
Sznitowska M et al. |
Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle.
|
29 |
Tarvainen T et al. |
Drug release from a porous ion-exchange membrane in vitro.
|
30 |
Tikkanen K, Finne J, inventors. |
Streptococcus suis adhesin protein and method for producing it.
|
31 |
Toroskainen C, Auriola S. |
Antibioottiset peptidit.
|
32 |
Vähätalo H et al. |
High-performance liquid chromatography-mass spectrometry of an osteocalcin derivative.
|
33 |
Ylitalo P et al. |
Comparison of pharmacokinetics of clodronate after single and repeated doses.
|